Based on this study, CD4+ T‐cell balance may be a helpful biomarker to assess immunologic responses, and increasing tumor‐reactive Teffs levels and depleting Tregs may be essential in establishing effective antitumor immunity. The gene discussed is CD4; the disease is neoplasm.